(Q41493791)

1 October 2017

[3H]MRS 1754, a selective antagonist radioligand for A(2B) adenosine receptors (English)

1 reference

1 October 2017

5

1 reference

1 October 2017

X Ji

1

1 reference

1 October 2017

Y C Kim

series ordinal

2

1 reference

1 October 2017

D G Ahern

series ordinal

3

1 reference

1 October 2017

J Linden

series ordinal

4

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

1 October 2017

Biochemical Pharmacology

1 reference

1 October 2017

61

1 reference

1 October 2017

6

1 reference

1 October 2017

657-663

1 reference

Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567772

Use of the triazolotriazine [3H]ZM 241385 as a radioligand at recombinant human A2B adenosine receptors

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567772

Adenosine receptor ligands: potential as therapeutic agents in asthma and COPD.

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567772

A functional screening of adenosine analogues at the adenosine A2B receptor: a search for potent agonists

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567772

Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567772

11 June 2018

Adenosine A2B receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567772

Pharmacological characterization of novel A3 adenosine receptor-selective antagonists

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567772

Canine Mast Cell Adenosine Receptors: Cloning and Expression of the A3Receptor and Evidence that Degranulation Is Mediated by the A2BReceptor

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567772

Functional characterization of the A2b adenosine receptor in NIH 3T3 fibroblasts

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567772

Positive modulation of intracellular Ca2+ levels by adenosine A2b receptors, prostacyclin, and prostaglandin E1 via a cholera toxin-sensitive mechanism in human erythroleukemia cells

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567772

Structure-activity relationships of 1,3-dialkylxanthine derivatives at rat A3 adenosine receptors

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567772

The A2b adenosine receptor mediates cAMP responses to adenosine receptor agonists in human intestinal epithelia

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567772

The in vitro pharmacology of ZM 241385, a potent, non‐xanthine, A2a selective adenosine receptor antagonist

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567772

Stimulation by alkylxanthines of chloride efflux in CFPAC-1 cells does not involve A1 adenosine receptors

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567772

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567772

A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567772

Adenosine A2B receptors: a novel therapeutic target in asthma?

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567772

Subclasses of adenosine receptors in the central nervous system: Interaction with caffeine and related methylxanthines

19 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900531-7

Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells

7 January 2021

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900531-7

10.1016/S0006-2952(01)00531-7

7 January 2021

Identifiers

DOI

1 reference

1 October 2017

1 reference

1 October 2017

PubMed publication ID

11266650

1 reference